Quick Summary
Koate-Dvi 250IU Injection
Last updated on 03 Aug 2026 | 06:24 AM (IST)
₹3714
MRP: ₹3910.32
(You Save ₹196.32)
1 VIAL(s)
Koate-Dvi 250IU Injection
Salt Composition
ANTI HEMOPHILIC FACTOR (HUMAN)Marketer
GRIFOLS
Prepaid Only. Non-Returnable.
5% OFF
₹3714
MRP: ₹3,910.32
Inclusive of all taxes
5% Off
Salt Composition
ANTI HEMOPHILIC FACTOR (HUMAN)Marketer
GRIFOLS
Prepaid Only. Non-Returnable.
Dispatch: Today
Care delivered without the wait. Your order is prioritized for rapid dispatch to ensure it reaches your doorstep on time.
Introduction to Koate-Dvi 250IU Injection
Koate-DVI 250IU Injection contains active components as Anti-hemophilic factor. It is, also known as factor VIII, is a medication used to treat hemophilia A, a genetic bleeding disorder caused by a blood clotting factor deficiency. It can be used to treat acute bleeding episodes in people with hemophilia A. This includes episodes of spontaneous bleeding and bleeding resulting from injuries or surgeries. People with hemophilia A may require surgery for various reasons, such as joint surgeries, dental procedures, or other medical interventions. It may be used before and after surgery to prevent excessive bleeding during and after the procedure.
Individuals with a known hypersensitivity or allergy to Koate-DVI 250IU Injection or any of its components should not use this medication. Allergic reactions to it can be severe and life-threatening. It should not be used to treat hemophilia B, which a deficiency of factor IX causes. There may be concerns about using it in individuals with severe kidney dysfunction or renal failure, as it can affect the clearance of the medication from the body. Dosing adjustments may be necessary in these cases. Individuals with pre-existing cardiovascular diseases, such as a history of heart attacks or thromboembolic events, may require careful monitoring and adjusted dosing when using Anti-hemophilic factors (human). It can be safe and effective for children and older adults with hemophilia A. Always follow the healthcare provider's recommendations for these groups.
Uses of Koate-Dvi 250IU Injection
Koate-DVI 250IU Injection is used in the following:
- Hemophilia A treatment
- Bleeding episode management
Therapeutic Effects of Koate-Dvi 250IU Injection
Koate-DVI 250IU Injection acts as a co-factor for factor IX in the formation of tenase complex, which is essential for the conversion of prothrombin to thrombin. Thrombin, in turn, facilitates the conversion of fibrinogen into fibrin, leading to the formation of stable blood clots. This medication corrects the clotting cascade, allowing individuals with hemophilia A to form normal blood clots and effectively manage bleeding episodes or prevent them when used prophylactically.
Interaction of Koate-Dvi 250IU Injection with other drugs
Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Koate-DVI 250IU Injection, reducing effectiveness by causing undesirable side effects.
More Information about Koate-Dvi 250IU Injection
- Stored at room temperature from 2°C to 8°C
- Keep away from moisture, heat, and light.
- It should not be frozen.
- Keep away from children and pets.
How to consume Koate-Dvi 250IU Injection
Koate-DVI 250IU Injection is typically administered intravenously (IV) through either peripheral venous access for home use or central venous access devices for those with frequent bleeding episodes or difficult peripheral venous access.
Safety Advice for Koate-Dvi 250IU Injection
Breast Feeding
It is not known whether an Koate-DVI 250IU Injection passes into breast milk. It is, therefore, important to talk to your doctor before using it if you are breastfeeding.
Alcohol
It's generally unsafe to take alcohol while on an Koate-DVI 250IU Injection. Alcohol can increase the risk of injury, which can be especially concerning for individuals with hemophilia A.
Liver
The liver plays a role in the clearance of clotting factors, so it is important to consult a healthcare provider before taking an Koate-DVI 250IU Injection.
Lungs
Koate-DVI 250IU Injection does not directly affect lung function. However, individuals with lung issues should consult a healthcare provider before using it.
Driving
Koate-DVI 250IU Injectiondoes not cause any side effects that would affect your ability to drive. However, if you experience dizziness or other unusual side effects, it's best to consult your healthcare provider.
Pregnancy
There is limited information on the safety of Koate-DVI 250IU Injection in pregnant women. It is, therefore, important to talk to your doctor before using it if you are pregnant.
Side Effects of Koate-Dvi 250IU Injection
Koate-DVI 250IU Injection causes some side effects like all medications, although not everyone will experience them.
Serious
- Allergic reactions
- Formation of inhibitors
- Thromboembolic events
- Circulatory overload
Common
- Infusion site reactions
- Headache
- Fever
- Chills
Word of Advice
When using an Koate-DVI 250IU Injection, it is important to be cautious of potential allergies, watch for inhibitors that can reduce its effectiveness, and take care if you have had blood clots or heart issues before. Kids and older adults might need different doses, and if you are pregnant or breastfeeding, consult your doctor. Proper storage, careful driving, and alcohol moderation are important. Watch for infection signs and plan for surgery. Learn how to use it correctly, discuss travel plans with your healthcare team, and seek support for your mental well-being. Inform your doctor about all medications if needed. In emergencies, know what to do for immediate bleeding control.
FAQs about Koate-Dvi 250IU Injection
Q1.
What should I do in a bleeding emergency using an Koate-DVI 250IU Injection?
In a bleeding emergency, individuals should follow their emergency treatment plan, administer Koate-DVI 250IU Injection as prescribed, and seek immediate medical attention if necessary. Proper preparedness can help control bleeding effectively.
Q2.
What are the serious side effects or complications associated with Koate-DVI 250IU Injection?
Serious side effects of Anti-hemophilic factors (human) can include allergic reactions (including anaphylaxis), the development of inhibitors, thromboembolic events (blood clots), and circulatory overload. Regular monitoring and communication with healthcare providers help manage these risks.
Q3.
Can I participate in sports and physical activities while on Koate-DVI 250IU Injection?
Individuals with hemophilia A can participate in sports and physical activities while on Koate-DVI 250IU Injection. Still, choosing activities that are safe and suitable for your condition is crucial. Consult with your healthcare team for exercise and sports participation guidance, and take necessary precautions to prevent injuries.
Q4.
What should I do if I miss a dose of Koate-DVI 250IU Injection?
If you miss a scheduled dose of Koate-DVI 250IU Injection, contact your healthcare provider or treatment center for guidance. They can help you determine whether you need to administer the missed dose and how to adjust your treatment plan.
Q5.
Can I self-administer the Koate-DVI 250IU Injection at home, or must I visit a healthcare facility for every infusion?
Many individuals with hemophilia A are trained to self-administer Anti-hemophilic factors (human) at home, especially for routine prophylactic infusions. Home administration can provide greater flexibility and convenience, but it's essential to receive proper training and guidance from your healthcare team.
Q6.
How often do I need to take the Koate-DVI 250IU Injection?
The frequency of Koate-DVI 250IU Injection infusions can vary depending on the individual's treatment plan and bleeding risk. Some people with hemophilia A may require prophylactic (preventive) infusions several times a week, while others may use it on an as-needed basis for bleeding episodes. Your healthcare team will determine the appropriate dosing schedule for you.
Fact Box of Koate-Dvi 250IU Injection
Molecule name: Anti-hemophilic factor (human) | Therapeutic class: Antihemorrhagics |
Pharmacological class: Clotting Factors | Indications: 1. Hemophilia A treatment 2. Bleeding episode management |
References
- KD Tripathi, Essentials of Medical Pharmacology, Drugs affecting coagulation, bleeding, and thrombosis, 7th edition, 2013, 217.
- Grifols Therapeutics Inc, [Revised on August 2012] [ Accessed on 15th Sept 2023], https://www.koate-dvi.com/documents/385822/0/Koate_DVI.pdf/fb455459-5ac0-43d3-bb48-363389a7c5c3?t=1414164745000
- Baxter Healthcare Corporation, US Food and Drug Administration, [Revised on March 2010] [ Accessed on 15th Sept 2023], https://www.fda.gov/media/78280/download
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Dr. Archana Gupta
BDS
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 03 Aug 2026 | 06:24 AM (IST)
Want to know more?
Read Our Editorial Policy
